REGENXBIO, Inc. RGNX 深 沪
等待开盘 03-26 09:30:00 美东时间
8.46
+0.650
+8.32%
华盛通- 最 高8.47
- 今 开8.04
- 成交量 93.09万股
- 最 低 8.04
- 昨 收 7.81
- 总市值 4.37亿
- 52周最高 16.19
- 市盈率 静 --
- 换手率 1.80%
- 52周最低 5.035
- 委 比 -42.86%
- 总股本 5161.30万
- 历史最高 85.10
- 量 比 0.84
- 振 幅 5.51%
- 历史最低 5.035
- 每 手 1
- 风险率 2.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Regenxbio Reports Duchenne Gene Therapy Progress As Stock Slides On Mixed Signals
Regenxbio releases new Duchenne trial data showing improved motor function and stable heart measures in early-stage patients.
03-12 02:19
美股大行评级 | 潜在涨幅148%！瑞银、小摩等8家大行首予SOLV Energy买入评级目标价42美元；甲骨文绩前遭德银等下调目标价；京东遭巴克莱下调目标价
今日重点评级关注：Evercore ISI集团：维持Caribou Biosciences"跑赢大市"评级，目标价从11美元升至13美元；富国银行：上调uniQure评级至"超配"，目标价从15美元升至60美元
03-10 15:05
Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Higher On Monday
US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer treatment data. Hims & Hers and Xenon Pharma jump over 40%.
03-09 22:05
股价盘前飙升34%！uniQure BV等公司因 FDA官员离职股价大涨！
（来源：invest wallstreet） uniQure BV (NASDAQ:QURE)股价周一飙升36%,此前有报道称美国食品药品监督管理局疫苗和基因治...
03-09 20:41
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
The Analyst Verdict: Regenxbio In The Eyes Of 8 Experts
Analysts' ratings for Regenxbio (NASDAQ:RGNX) over the last quarter vary from b...
03-07 02:01
Morgan Stanley Maintains Overweight on Regenxbio, Lowers Price Target to $17
Morgan Stanley analyst Judah Frommer maintains Regenxbio (NASDAQ:RGNX) with a Overweight and lowers the price target from $18 to $17.
03-06 23:57
RGNX'S "TRANSFORMATIONAL" PROMISE BECAME A $2.40 LOSS FOR INVESTORS: SUEWALLST
Promise vs. Reality: The REGENXBIO Gene Therapy Performance Gap NEW YORK, March 5, 2026 /PRNewswire/ -- "Very promising results." That is how REGENXBIO, Inc. (NASDAQ: RGNX) characterized its...
03-06 03:25
Regenxbio Earnings Report: Q4 Overview
Regenxbio (NASDAQ:RGNX) just disclosed its Q4 earnings on Thursday, March 5, 20...
03-05 20:10
